{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:06:41Z","timestamp":1793639201555,"version":"4.5.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jns.2026.125940","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T06:52:00Z","timestamp":1776754320000},"page":"125940","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Overlapping features of posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome"],"prefix":"10.1016","volume":"486","author":[{"given":"Karlo","family":"Toljan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moein","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Scarsella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megha","family":"Purohit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naresh","family":"Mullaguri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolora","family":"Wisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumei","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Uchino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2026.125940_bb0005","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199602223340803","article-title":"A reversible posterior leukoencephalopathy syndrome","volume":"334","author":"Hinchey","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2026.125940_bb0010","doi-asserted-by":"crossref","first-page":"34","DOI":"10.7326\/0003-4819-146-1-200701020-00007","article-title":"Narrative review: reversible cerebral vasoconstriction syndromes","volume":"146","author":"Calabrese","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jns.2026.125940_bb0015","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1212\/CON.0000000000001037","article-title":"Posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome as syndromes of cerebrovascular dysregulation","volume":"27","author":"Singhal","year":"2021","journal-title":"Continuum (Lifelong Learning Neurol.)."},{"key":"10.1016\/j.jns.2026.125940_bb0020","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fneur.2020.00034","article-title":"Posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome: clinical and radiological considerations","volume":"11","author":"Pilato","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2026.125940_bb0025","article-title":"Addressing PRES and RCVS: two distinct entities or a spectrum of the same disease?","author":"Motolese","year":"2022","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.jns.2026.125940_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106472","article-title":"PRES and RCVS: two distinct entities or a spectrum of the same disease?","volume":"31","author":"Jeanneret","year":"2022","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.jns.2026.125940_bb0035","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/ana.24652","article-title":"Reversible cerebral vasoconstriction syndromes and primary Angiitis of the central nervous system: clinical, imaging, and angiographic comparison: RCVS and PACNS","volume":"79","author":"Singhal","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2026.125940_bb0040","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1468-2982.2009.01868.x","article-title":"Reversible cerebral vasoconstriction syndrome with posterior Leucoencephalopathy after oral contraceptive pills","volume":"30","author":"Soo","year":"2010","journal-title":"Cephalalgia"},{"key":"10.1016\/j.jns.2026.125940_bb0045","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1212\/WNL.0b013e3181feb299","article-title":"Licorice-associated reversible cerebral vasoconstriction with PRES","volume":"75","author":"Chatterjee","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2026.125940_bb0050","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/archneur.61.3.411","article-title":"Postpartum angiopathy with reversible posterior leukoencephalopathy","volume":"61","author":"Singhal","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2026.125940_bb0055","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.2169\/internalmedicine.50.4812","article-title":"Reversible cerebral vasoconstriction syndrome presenting as subarachnoid hemorrhage, reversible posterior leukoencephalopathy, and cerebral infarction","volume":"50","author":"Noda","year":"2011","journal-title":"Intern. Med."},{"key":"10.1016\/j.jns.2026.125940_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2019.105489","article-title":"Malignant PRES and RCVS after brain surgery in the early postpartum period","volume":"185","author":"Cossu","year":"2019","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.jns.2026.125940_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J. Biomed. Inform."},{"key":"10.1016\/j.jns.2026.125940_bb0070","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1161\/STROKEAHA.121.034424","article-title":"Outcomes among patients with reversible cerebral vasoconstriction syndrome: a nationwide United States analysis","volume":"52","author":"Patel","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2026.125940_bb0075","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1161\/STROKEAHA.109.572313","article-title":"Hemorrhagic manifestations of reversible cerebral vasoconstriction syndrome: frequency, features, and risk factors","volume":"41","author":"Ducros","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2026.125940_bb0080","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00415-022-11425-z","article-title":"RCVS: by clinicians for clinicians\u2014a narrative review","volume":"270","author":"Erhart","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2026.125940_bb0085","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1007\/s00415-016-8377-8","article-title":"Posterior reversible encephalopathy syndrome","volume":"264","author":"Fischer","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2026.125940_bb0090","doi-asserted-by":"crossref","DOI":"10.1136\/practneurol-2021-003194","article-title":"Posterior reversible encephalopathy syndrome (PRES): diagnosis and management","author":"Triplett","year":"2022","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.jns.2026.125940_bb0095","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fneur.2020.00071","article-title":"Posterior reversible encephalopathy syndrome: clinical features and outcome","volume":"11","author":"Hinduja","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2026.125940_bb0100","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3174\/ajnr.A0839","article-title":"Catheter angiography, MR Angiography, and MR Perfusion in posterior reversible encephalopathy syndrome","volume":"29","author":"Bartynski","year":"2008","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.jns.2026.125940_bb0105","first-page":"49","article-title":"Red cell distribution width as a novel prognostic marker in multiple clinical studies, Indian","volume":"24","author":"Yousefi","year":"2020","journal-title":"J. Crit. Care Med."},{"key":"10.1016\/j.jns.2026.125940_bb0110","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12974-021-02090-6","article-title":"The association of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and lymphocyte to monocyte ratio with post-thrombolysis early neurological outcomes in patients with acute ischemic stroke","volume":"18","author":"Gong","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jns.2026.125940_bb0115","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1001\/archneurol.2011.68","article-title":"Reversible cerebral vasoconstriction syndromes: analysis of 139 cases","volume":"68","author":"Singhal","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2026.125940_bb0120","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/1941874418802061","article-title":"Cerebrospinal fluid in posterior reversible encephalopathy syndrome: implications of elevated protein and pleocytosis","volume":"9","author":"Ellis","year":"2019","journal-title":"Neurohospitalist"},{"key":"10.1016\/j.jns.2026.125940_bb0125","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/ana.21951","article-title":"Magnetic resonance angiography in reversible cerebral vasoconstriction syndromes","volume":"67","author":"Chen","year":"2010","journal-title":"Ann. Neurol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26002224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26002224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T20:07:22Z","timestamp":1778702842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X26002224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":25,"alternative-id":["S0022510X26002224"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2026.125940","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overlapping features of posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2026.125940","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"125940"}}